MediumCardiologyHeart failure with reduced ejection fractionau-amcau-racp
A 70-year-old man with ischaemic cardiomyopathy has left ventricular ejection fraction 30% and NYHA class II symptoms despite optimal diuretics. He is in sinus rhythm with a resting heart rate of 78 beats/min and blood pressure 118/70 mmHg. Which medication has the greatest proven mortality benefit when introduced or up-titrated in heart failure with reduced ejection fraction?